Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

The deal is expected to close in late Q2 2025, subject to Nevro shareholder and regulatory approval.Globus Medical also ...

From acquisitions and new leadership, here are six key updates from spine and orthopedic device companies since March 26: 1.

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...

Globus Medical, Inc. GMED continues to benefit from ... Globus is also optimistic about the recently inked deal to acquire Nevro Corporation. The acquisition of Nevro is expected to expand Globus ...

citing the company’s impressive performance and potential synergies from its recent acquisition of Nevro Corp. This acquisition is anticipated to influence Globus Medical’s 2025 financial ...

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further ...